Top Industry Leaders in the Vesicoureteral Reflux Market
Latest Vesicoureteral Reflux Companies Update
Boston Scientific (US) Received FDA clearance for its new Acuity Reflux Control System, a minimally invasive device for treating moderate VUR in children. The system uses a small implant placed in the ureter to prevent urine from backing up into the kidneys.
Medtronic (US) Announced the launch of its VMPure ureteral stents, designed specifically for VUR treatment. The stents are made of a biocompatible material that minimizes inflammation and discomfort for patients.
Coloplast (Denmark) Introduced its new PerClot embolic beads for treating VUR in adults. The beads are injected into the ureter to block the flow of urine and promote natural healing.
List of Vesicoureteral Reflux Key companies in the market
- Salix Pharmaceuticals
- Q-Med Scandinavia Inc.
- Cook Medical
- Salix Pharmaceuticals, Ltd.
- Bayer AG
- Novartis AG
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd